AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally.
It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets.
It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors.
The company was incorporated in 1969 and is headquartered in Newport Beach, California.
Country | United States |
IPO Date | Mar 3, 1987 |
Industry | Agricultural Inputs |
Sector | Basic Materials |
Employees | 845 |
CEO | Douglas A. Kaye III CPA |
Contact Details
Address: 4695 MacArthur Court Newport Beach, California United States | |
Website | https://www.american-vanguard.com |
Stock Details
Ticker Symbol | AVD |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000005981 |
CUSIP Number | 030371108 |
ISIN Number | US0303711081 |
Employer ID | 95-2588080 |
SIC Code | 2870 |
Key Executives
Name | Position |
---|---|
Douglas A. Kaye III CPA | Chief Executive Officer |
David T. Johnson C.F.A. | Vice President, Chief Financial Officer & Treasurer |
Andrew B. Naughton | Vice President & Director of Technology |
Donald J. Gualdoni | Chief Transformation Officer |
James Thompson | Director of Business Development, Portfolio Management Biologicals & Non-Crop |
Peter E. Eilers | Managing Director of AMVAC Netherlands BV |
Robert F. Gilbane | President of Gemchem Inc |
Shirin Khosravi | Senior Vice President of Human Resources |
Timothy J. Donnelly Esq. | General Counsel, Chief Administrative Officer & Secretary |
William A. Kuser | Director of Investor Relations & Corporate Communications |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 14, 2025 | 3 | Filing |
Jan 10, 2025 | 3 | Filing |
Dec 17, 2024 | 4 | Filing |
Dec 13, 2024 | 8-K | Current Report |
Dec 06, 2024 | 8-K | Current Report |
Nov 18, 2024 | 4 | Filing |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 12, 2024 | 10-Q | Quarterly Report |
Nov 12, 2024 | 8-K | Current Report |
Oct 31, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |